A carregar...
Antioxidants in Down Syndrome: From Preclinical Studies to Clinical Trials
There is currently no effective pharmacological therapy to improve the cognitive dysfunction of individuals with Down syndrome (DS). Due to the overexpression of several chromosome 21 genes, cellular and systemic oxidative stress (OS) is one of the most important neuropathological processes that con...
Na minha lista:
| Publicado no: | Antioxidants (Basel) |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7464577/ https://ncbi.nlm.nih.gov/pubmed/32756318 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/antiox9080692 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|